Stock Options, Restricted Stock Units and Warrants (Details) - Schedule of restricted stock unit - Restricted stock units [Member] |
9 Months Ended |
---|---|
Sep. 30, 2022
$ / shares
shares
| |
Stock Options, Restricted Stock Units and Warrants (Details) - Schedule of restricted stock unit [Line Items] | |
Number of Shares, Unvested, Beginning | shares | 1,939,683 |
Weighted Average Grant-Date Fair Value, Unvested, Beginning | $ / shares | $ 3.4 |
Number of Shares, Unvested, Ending | shares | 887,462 |
Weighted Average Grant-Date Fair Value, Unvested, Ending | $ / shares | $ 2.3 |
Number of Shares, Granted | shares | 576,350 |
Weighted Average Grant-Date Fair Value, Granted | $ / shares | $ 0.62 |
Number of Shares, Vested | shares | (566,666) |
Weighted Average Grant-Date Fair Value, Vested | $ / shares | $ 2.81 |
Number of Shares, Issued | shares | (1,061,905) |
Weighted Average Grant-Date Fair Value, Issued | $ / shares | $ 4.5 |
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- Definition The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan). Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Gross number of share options (or share units) granted during the period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Number of shares issued under share-based payment arrangement. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Weighted average grant-date fair value of non-vested options outstanding. No definition available.
|
X | ||||||||||
- Definition Weighted average grant-date fair value of options vested. No definition available.
|
X | ||||||||||
- Details
|